-
公开(公告)号：US09512189B2
公开(公告)日：2016-12-06
申请号：US14237133
申请日：2012-08-06
CPC分类号： C07K14/44 , A61K39/00 , A61K39/0002 , A61K2039/55566 , C07K16/20 , C12N9/0051
摘要： Immunologically active agents are described, including isolated Pneumocystis A 12 protein or polypeptides; immunogenic conjugates containing Pneumocystis A 12 protein or polypeptide of the present invention; antibodies recognizing the Pneumocystis A 12 protein or polypeptide or the immunogenic conjugates of the present invention; and nucleic acid molecules that encode the Pneumocystis A 12 protein or polypeptide of the present invention, as well as DNA constructs, expression vectors, and host cells that contain the nucleic acid molecules. Disclosed uses of the antibodies, immunogenic conjugates, and DNA constructs include inducing passive or active immunity to treat or prevent pathogen infections, particularly by a Pneumocystis organism, in a subject.
摘要翻译： 描述了免疫活性剂，包括分离的肺孢子虫A12蛋白或多肽; 含有本发明的肺囊虫A12蛋白或多肽的免疫原性缀合物; 识别本发明的肺孢子虫A12蛋白或多肽或免疫原性缀合物的抗体; 和编码本发明的肺囊虫A12蛋白或多肽的核酸分子，以及含有核酸分子的DNA构建体，表达载体和宿主细胞。 抗体，免疫原性缀合物和DNA构建体的公开用途包括在受试者中诱导被动或主动免疫以治疗或预防病原体感染，特别是肺囊虫生物体的感染。
-
公开(公告)号：US20140271656A1
公开(公告)日：2014-09-18
申请号：US14237133
申请日：2012-08-06
CPC分类号： C07K14/44 , A61K39/00 , A61K39/0002 , A61K2039/55566 , C07K16/20 , C12N9/0051
摘要： Immunologically active agents are described, including isolated Pneumocystis A 12 protein or polypeptides; immunogenic conjugates containing Pneumocystis A 12 protein or polypeptide of the present invention; antibodies recognizing the Pneumocystis A 12 protein or polypeptide or the immunogenic conjugates of the present invention; and nucleic acid molecules that encode the Pneumocystis A 12 protein or polypeptide of the present invention, as well as DNA constructs, expression vectors, and host cells that contain the nucleic acid molecules. Disclosed uses of the antibodies, immunogenic conjugates, and DNA constructs include inducing passive or active immunity to treat or prevent pathogen infections, particularly by a Pneumocystis organism, in a subject.
摘要翻译： 描述了免疫活性剂，包括分离的肺孢子虫A12蛋白或多肽; 含有本发明的肺囊虫A12蛋白或多肽的免疫原性缀合物; 识别本发明的肺孢子虫A12蛋白或多肽或免疫原性缀合物的抗体; 和编码本发明的肺囊虫A12蛋白或多肽的核酸分子，以及含有核酸分子的DNA构建体，表达载体和宿主细胞。 抗体，免疫原性缀合物和DNA构建体的公开用途包括在受试者中诱导被动或主动免疫以治疗或预防病原体感染，特别是肺囊虫生物体的感染。
-
3.发明申请Polypeptides And Immunogenic Conjugates Capable of Inducing Antibodies Against Pathogens, and Uses Thereof 有权能够诱导抗病原体抗体的多肽和免疫原性缀合物及其用途公开(公告)号：US20080171053A1
公开(公告)日：2008-07-17
申请号：US10584871
申请日：2004-12-31
申请人： Francis Gigliotti , Terry W. Wright , Constantine G. Haidaris , Patricia J. Simpson-Haidaris , Jesse Wells
发明人： Francis Gigliotti , Terry W. Wright , Constantine G. Haidaris , Patricia J. Simpson-Haidaris , Jesse Wells
IPC分类号： A61K39/40 , A61K39/02 , C07K14/315
CPC分类号： C07K14/37 , A61K39/00 , A61K2039/505 , C07K14/3156 , Y10S530/823
摘要： A number of immunologically active agents are described, including an isolated protein or polypeptide that includes the amino acid sequence of SEQ ID NO: 1, immunogenic conjugates containing either the protein or polypeptide, a full-length Pneumocystis kexin, or a full length Streptococcus pneumoniae pneumococcal surface protein A (PspA), antibodies recognizing the protein or polypeptide or the immunogenic conjugates (particularly the epitope of SEQ ID NO: 1), and nucleic acid molecules that encode the protein or polypeptide, as well as DNA constructs, expression vectors, and host cells that contain the nucleic acid molecules. Disclosed uses of the antibodies, immunogenic conjugates, and DNA constructs include inducing passive or active immunity to treat or prevent pathogen infections, particularly by a Pneumocystis organism, in a patient.
摘要翻译： 描述了许多免疫活性剂，包括分离的蛋白质或多肽，其包括SEQ ID NO：1的氨基酸序列，含有蛋白质或多肽的免疫原性缀合物，全长肺孢子虫Kexin或全长肺炎链球菌 肺炎球菌表面蛋白A（PspA），识别蛋白质或多肽或免疫原性缀合物（特别是SEQ ID NO：1的表位）的抗体，以及编码蛋白质或多肽的核酸分子，以及DNA构建体，表达载体， 和含有核酸分子的宿主细胞。 抗体，免疫原性缀合物和DNA构建体的公开用途包括诱导被动或主动免疫以治疗或预防患者中特别是肺孢子虫生物体的病原体感染。
-
4.发明授权Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof 有权能够诱导针对病原体的抗体的多肽和免疫原性缀合物及其用途公开(公告)号：US07815918B2
公开(公告)日：2010-10-19
申请号：US10584871
申请日：2004-12-31
申请人： Francis Gigliotti , Terry W. Wright , Constantine G. Haidaris , Patricia J. Simpsonhaidaris , Jesse Wells
发明人： Francis Gigliotti , Terry W. Wright , Constantine G. Haidaris , Patricia J. Simpsonhaidaris , Jesse Wells
CPC分类号： C07K14/37 , A61K39/00 , A61K2039/505 , C07K14/3156 , Y10S530/823
摘要： A number of immunologically active agents are described, including an isolated protein or polypeptide that includes the amino acid sequence of SEQ ID NO: 1, immunogenic conjugates containing either the protein or polypeptide, a full-length Pneumocystis kexin, or a full length Streptococcus pneumoniae pneumococcal surface protein A (PspA), antibodies recognizing the protein or polypeptide or the immunogenic conjugates (particularly the epitope of SEQ ID NO: 1), and nucleic acid molecules that encode the protein or polypeptide, as well as DNA constructs, expression vectors, and host cells that contain the nucleic acid molecules. Disclosed uses of the antibodies, immunogenic conjugates, and DNA constructs include inducing passive or active immunity to treat or prevent pathogen infections, particularly by a Pneumocystis organism, in a patient.
摘要翻译： 描述了许多免疫活性剂，包括分离的蛋白质或多肽，其包括SEQ ID NO：1的氨基酸序列，含有蛋白质或多肽的免疫原性缀合物，全长肺孢子虫Kexin或全长肺炎链球菌 肺炎球菌表面蛋白A（PspA），识别蛋白质或多肽或免疫原性缀合物（特别是SEQ ID NO：1的表位）的抗体，以及编码蛋白质或多肽的核酸分子，以及DNA构建体，表达载体， 和含有核酸分子的宿主细胞。 抗体，免疫原性缀合物和DNA构建体的公开用途包括诱导被动或主动免疫以治疗或预防患者中特别是肺孢子虫生物体的病原体感染。
-
公开(公告)号：US4689299A
公开(公告)日：1987-08-25
申请号：US534658
申请日：1983-09-22
CPC分类号： C07K16/1282 , C07K16/1285
摘要： The production of stable hybrid cell lines that secrete human monoclonal antibodies against bacterial toxins by fusing post-immunization human peripheral blood lymphocytes with nonsecretor mouse myeloma cells is described. Using the method, protective monoclonal antibodies against tetanus toxin and diphtheria toxin were produced that bind tetanus toxin and diphtheria toxin in vitro, respectively, and prevent tetanus and diphtheria in vivo in animals, respectively.
摘要翻译： 描述了通过将免疫后外周血淋巴细胞与未分离的小鼠骨髓瘤细胞融合来分泌针对细菌毒素的人单克隆抗体的稳定杂交细胞系的产生。 使用该方法，分别在体外分别结合破伤风毒素和白喉毒素的破伤风毒素和白喉毒素的保护性单克隆抗体，并分别在动物体内预防破伤风和白喉。
-
-
-
-
搜索结果
5 条记录 (耗时 0.047 秒)
